CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 75 enrolled
Drug / intervention
Naltrexone and memantine first +1 moredrug
Likely dose
Naltrexone and memantine first 50mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01519063
NCT01519063Phase 2Completed
CompareCT.gov

Glutamate-opioid Interactions in Alcohol Drinking Behaviors

Yale University·interventional·Posted Jan 26, 2012·Updated Mar 9, 2020

In Brief

A Phase 2 clinical trial evaluating Naltrexone and memantine first and Naltrexone and Placebo first for Alcohol Drinking. Completed, enrolled 75 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the combined effects of the study medications naltrexone and memantine on alcohol drinking behaviors.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlcohol Drinking
CountriesUnited States
CollaboratorsNational Institute on Alcohol Abuse and Alcoholism (NIAAA)

Timeline

Phase 2CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJan 26, 2012
Enrollment StartJan 1, 2012
Primary CompletionMar 29, 2017
Study CompletionMay 1, 2017
TodayJul 2, 2026
Enrollment to primary: 5.2 yearsPosted 14.4 years ago

Interventions

Naltrexone and memantine firstdrug

Naltrexone 50mg memantine 20mg

Naltrexone and Placebo firstdrug

Naltrexone 50 mg Placebo